Revelation Biosciences Stock Analysis
| REVBW Stock | USD 0.02 0.0007 4.37% |
Revelation Biosciences is overvalued with Real Value of 0.014 and Hype Value of 0.02. The main objective of Revelation Biosciences stock analysis is to determine its intrinsic value, which is an estimate of what Revelation Biosciences is worth, separate from its market price. There are two main types of Revelation Biosciences' stock analysis: fundamental analysis and technical analysis.
The Revelation Biosciences stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Revelation Biosciences is usually not traded on New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day. Revelation Stock trading window is adjusted to America/New York timezone.
Revelation |
Revelation Stock Analysis Notes
The company recorded a loss per share of 4.77. Revelation Biosciences had not issued any dividends in recent years. Revelation Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of immunologic-based therapeutics and diagnostics for the prevention and treatment of disease. The company was founded in 2019 and is based in New York, New York. Revelation Biosciences is traded on NASDAQ Exchange in the United States. To find out more about Revelation Biosciences contact James Rolke at 650 800 3717 or learn more at https://www.revbiosciences.com.Revelation Biosciences Investment Alerts
| Revelation Biosciences had very high historical volatility over the last 90 days | |
| Revelation Biosciences has some characteristics of a very speculative penny stock | |
| Revelation Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (120.25 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Revelation Biosciences has accumulated about 4.14 M in cash with (7.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.79, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Revelation Biosciences has a frail financial position based on the latest SEC disclosures |
Revelation Biosciences Thematic Classifications
In addition to having Revelation Biosciences stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | BiotechBiotechnology and pharmaceuticals production and services |
Revelation Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.01) | (0.01) | |
| Return On Capital Employed | (1.30) | (1.24) | |
| Return On Assets | (0.01) | (0.01) | |
| Return On Equity | (0.02) | (0.02) |
Management Efficiency
The company has return on total asset (ROA) of (0.3405) % which means that it has lost $0.3405 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.9195) %, meaning that it generated substantial loss on money invested by shareholders. Revelation Biosciences' management efficiency ratios could be used to measure how well Revelation Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.01 in 2024. Return On Capital Employed is likely to climb to -1.24 in 2024. Total Assets is likely to climb to about 12.8 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 129.4 K in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 29.16 | 27.70 | |
| Tangible Book Value Per Share | 29.16 | 27.70 | |
| Enterprise Value Over EBITDA | 0.99 | 1.04 | |
| Price Book Value Ratio | 0.52 | 0.54 | |
| Enterprise Value Multiple | 0.99 | 1.04 | |
| Price Fair Value | 0.52 | 0.54 | |
| Enterprise Value | -1.9 M | -1.8 M |
The analysis of Revelation Biosciences' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Revelation Biosciences' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Revelation Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta 0.188 | Return On Assets (0.34) | Return On Equity (0.92) |
Technical Drivers
As of the 26th of June, Revelation Biosciences holds the Risk Adjusted Performance of 0.0363, coefficient of variation of 2465.41, and Semi Deviation of 12.25. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Revelation Biosciences, as well as the relationship between them. Please check Revelation Biosciences standard deviation, as well as the relationship between the value at risk and kurtosis to decide if Revelation Biosciences is priced some-what accurately, providing market reflects its current price of 0.0167 per share. As Revelation Biosciences appears to be a penny stock we also advise to check out its total risk alpha numbers.Revelation Biosciences Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Revelation Biosciences middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Revelation Biosciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Revelation Biosciences Predictive Daily Indicators
Revelation Biosciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Revelation Biosciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 0.41 | |||
| Daily Balance Of Power | 0.0761 | |||
| Rate Of Daily Change | 1.04 | |||
| Day Median Price | 0.0176 | |||
| Day Typical Price | 0.0173 | |||
| Market Facilitation Index | 0.0092 | |||
| Price Action Indicator | (0.0006) | |||
| Period Momentum Indicator | 7.0E-4 | |||
| Relative Strength Index | 38.05 |
Revelation Biosciences Forecast Models
Revelation Biosciences' time-series forecasting models are one of many Revelation Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Revelation Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Revelation Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Revelation Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Revelation shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Revelation Biosciences. By using and applying Revelation Stock analysis, traders can create a robust methodology for identifying Revelation entry and exit points for their positions.
| Last Reported | Projected for Next Year |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Revelation Biosciences to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Bollinger Bands Now
Bollinger BandsUse Bollinger Bands indicator to analyze target price for a given investing horizon |
| All Next | Launch Module |
Additional Tools for Revelation Stock Analysis
When running Revelation Biosciences' price analysis, check to measure Revelation Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revelation Biosciences is operating at the current time. Most of Revelation Biosciences' value examination focuses on studying past and present price action to predict the probability of Revelation Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revelation Biosciences' price. Additionally, you may evaluate how the addition of Revelation Biosciences to your portfolios can decrease your overall portfolio volatility.